诚意药业：关于公司药品通过仿制药一致性评价的公告

Core Points - Chengyi Pharmaceutical has received approval from the National Medical Products Administration for its supplemental drug application for the production of Dopamine Hydrochloride Injection, which has passed the consistency evaluation of quality and efficacy for generic drugs [1] Group 1 - The approval signifies a significant milestone for Chengyi Pharmaceutical in the generic drug market [1] - The successful evaluation enhances the company's product portfolio and may lead to increased market competitiveness [1]